首页> 美国卫生研究院文献>Journal of Biomechanical Engineering >In vitro Articular Cartilage Growth with Sequential Application of IGF-1 and TGF-β1 Enhances Volumetric Growth and Maintains Compressive Properties
【2h】

In vitro Articular Cartilage Growth with Sequential Application of IGF-1 and TGF-β1 Enhances Volumetric Growth and Maintains Compressive Properties

机译:连续应用IGF-1和TGF-β1进行的体外关节软骨生长可促进体积生长并保持抗压特性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In vitro cultures with insulin-like growth factor-1 (IGF-1) and transforming growth factor-β1 (TGF-β1) have previously been shown to differentially modulate the growth of immature bovine articular cartilage. IGF-1 stimulates expansive growth yet decreases compressive moduli and increases compressive Poisson’s ratios, whereas TGF-β1 maintains tissue size, increases compressive moduli, and decreases compressive Poisson’s ratios. The current study’s hypothesis was that sequential application of IGF-1 and TGF-β1 during in vitro culture produces geometric and compressive mechanical properties that lie between extreme values produced when using either growth factor alone. Immature bovine articular cartilage specimens were harvested and either untreated (D0, i.e., day zero) or cultured in vitro for either 6 days with IGF-1 (D6 IGF), 12 days with IGF-1 (D12 IGF), or 6 days with IGF-1 followed by 6 days with TGF-β1 (D12 SEQ, i.e., sequential). Following treatment, all specimens were tested for geometric, biochemical, and compressive mechanical properties. Relative to D0, D12 SEQ treatment enhanced volumetric growth, but to a lower value than that for D12 IGF. Furthermore, D12 SEQ treatment maintained compressive moduli and Poisson’s ratios at values higher and lower, respectively, than those for D12 IGF. Considering the previously described effects of 12 days of treatment with TGF-β1 alone, D12 SEQ induced both growth and mechanical property changes between those produced with either IGF-1 or TGF-β1 alone. The results suggest that it may be possible to vary the durations of select growth factors, including IGF-1 and TGF-β1, to more precisely modulate the geometric, biochemical, and mechanical properties of immature cartilage graft tissue in clinical repair strategies.
机译:先前已显示具有胰岛素样生长因子-1(IGF-1)和转化生长因子-β1(TGF-β1)的体外培养物可差异地调节未成熟牛关节软骨的生长。 IGF-1刺激扩张性生长,但降低了压缩模量并增加了压缩泊松比,而TGF-β1保持了组织大小,增加了压缩模量并降低了压缩泊松比。当前研究的假设是,在体外培养过程中连续施用IGF-1和TGF-β1会产生几何和压缩机械性能,介于单独使用任一生长因子时产生的极值之间。收获未成熟的牛关节软骨标本,不进行处理(D0,即零日),或者用IGF-1(D6 IGF)体外培养6天,用IGF-1(D12 IGF)体外培养12天,或者用IGF-1(D12 IGF)体外培养6天。 IGF-1,然后是6天的TGF-β1(D12 SEQ,即顺序的)。处理后,测试所有标本的几何,生化和压缩机械性能。相对于D0,D12 SEQ处理增强了体积生长,但比D12 IGF的值低。此外,D12 SEQ处理的压缩模量和泊松比分别保持在比D12 IGF更高的值和更低的值。考虑到先前描述的单独使用TGF-β1治疗12天的效果,D12 SEQ诱导了单独使用IGF-1或TGF-β1产生的生长和力学性能的变化。结果表明,可能有可能改变包括IGF-1和TGF-β1在内的某些生长因子的持续时间,以在临床修复策略中更精确地调节未成熟软骨移植组织的几何,生化和力学性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号